Related Experiment Video
Updated: Aug 22, 2026
The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
Ultraviolet light selection assay to optimize oligonucleotide correction of mutations in endogenous xeroderma
1Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Abstract:
Various oligonucleotide (ODN)-based approaches have been proposed for their ability to correct mutated genes at the normal chromosomal locations. However, the reported gene correction frequencies of these approaches have varied markedly in different experimental settings, including when different tissues or cell types are targeted. In order to find the optimal ODN-based approach for a specific target tissue, an assay system that allows direct comparison of the different methods on that tissue is necessary. Herein, we describe an XP-UVC selection assay that can be used to evaluate and compare gene correction frequencies in different cell types obtained from a xeroderma pigmentosum (XP) patient, following treatment by different ODN-based approaches. As an experimental example, the XP-UVC selection assay was used to assess the ability of chimeric RNA/DNA ODN to correct point mutations in the XPA gene. This assay can be used to assess and evaluate other types of ODN-based approaches, and to further optimize them.
Insights
Developing a novel assay system is crucial for comparing oligonucleotide (ODN)-based gene correction methods across different cell types. This new XP-UVC selection assay enables direct evaluation of ODN approaches for optimizing gene repair strategies.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Oligonucleotide (ODN)-based strategies aim to correct mutated genes at chromosomal locations.
- Gene correction frequencies vary significantly across different tissues and cell types.
- A standardized assay is needed to compare ODN-based approaches for specific target tissues.
Purpose of the Study:
- To develop and validate an assay system for comparing the efficiency of different ODN-based gene correction methods.
- To establish a method for evaluating gene correction frequencies in diverse cell types from xeroderma pigmentosum (XP) patients.
- To facilitate the optimization of ODN-based gene repair strategies for specific cellular contexts.
Main Methods:
- Development of an XP-UVC selection assay system.
- Utilizing cell types derived from xeroderma pigmentosum (XP) patients.
- Application of the assay to evaluate chimeric RNA/DNA ODN for correcting XPA gene mutations.
Main Results:
- The XP-UVC selection assay effectively evaluates and compares gene correction frequencies across different cell types.
- Demonstrated the utility of the assay in assessing ODN-based correction of point mutations in the XPA gene.
- The assay provides a platform for direct comparison of various ODN-based gene correction approaches.
Conclusions:
- The described XP-UVC selection assay is a valuable tool for assessing ODN-based gene correction efficiencies.
- This assay system enables direct comparison and optimization of gene correction strategies in specific cell types.
- The methodology can be adapted to evaluate diverse ODN-based approaches for therapeutic applications.
Related Concept Videos
01:38Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
01:08Nucleotide Excision Repair
01:35Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...